Lactulosum Polfarmex : Uses, Side Effects, Interactions, Dosage / Pillintrip
The information provided in Name of the medicinal product of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Name of the medicinal product in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
The information provided in Qualitative and quantitative composition of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Qualitative and quantitative composition in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
The information provided in Therapeutic indications of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Therapeutic indications in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
The information provided in Dosage (Posology) and method of administration of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Dosage (Posology) and method of administration in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
Laevolac may be administered diluted or undiluted. The dose should be titrated according to the clinical response. Lactulosum Polfarmex may be given as a single daily dose or in two to three divided doses.
A single dose of Lactulosum Polfarmex should be swallowed in one and should not be kept in the mouth for an extended period of time.
1-3 sachets, corresponding to 10-30 g Lactulosum Polfarmex
1 sachet, corresponding to 10 g Lactulosum Polfarmex
For a precise dosing for infants, toddlers and children up to 6 years, Lactulosum Polfarmex is available in bottles.
The information provided in Contraindications of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Contraindications in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
The information provided in Special warnings and precautions for use of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Special warnings and precautions for use in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
Lactulosum Polfarmex should be administered with care to patients who are intolerant to lactose.
Lactulosum Polfarmex may contain more than 5 g lactose/galactose/epilactose depending upon the dose taken. This should be taken into account in patients with diabetes mellitus.15 ml of Lactulosum Polfarmex contain 42.7 KJ (10.2 kcals) = 0.21 BU.
For patients with gastro-cardiac syndrome (Roemheld syndrome) Lactulosum Polfarmex should only be taken after consultation of a physician. If symptoms like meteorism or bloating occur in such patients after Lactulosum Polfarmex intake, the dose should be reduced or the treatment should be discontinued.
For elderly patients or patients that are in bad general condition and take Lactulosum Polfarmex for a more than 6 months period, periodic control of electrolytes is indicated.
Lactulosum Polfarmex should be administrated with caution in infants and small children with autosomal recessive hereditary fructose intolerance.
The defecation reflex may be altered during the treatment with Lactulosum Polfarmex.
The information provided in Effects on ability to drive and use machines of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Effects on ability to drive and use machines in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
The information provided in Undesirable effects of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Undesirable effects in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
The information provided in Overdose of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Overdose in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
The information provided in Pharmacodynamic properties of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Pharmacodynamic properties in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
Lactulosum Polfarmex is a synthetic disaccharide formed from D-galactose and fructose. Lactulosum Polfarmex as a prebiotic substance strengthens the growth of bifidobacteria and lactobacilli, whereas Clostridium and Escherichia coli may be suppressed.
In the colon Lactulosum Polfarmex is metabolised by bacterial enzymes to short chain fatty acids mainly lactic and acetic acid as well as methane and hydrogen. This effect leads to a decrease of the pH-value and an increase of the osmotic pressure in the colon. This causes stimulation of peristalsis and an increase of the water content of the faeces.
The information provided in Pharmacokinetic properties of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Pharmacokinetic properties in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
Lactulosum Polfarmex is practically not absorbed, because in man there is no corresponding disaccharidase available in the upper intestinal tract. Not being absorbed as such, it reaches the colon unchanged. There it is metabolised by the colonic bacterial flora. Metabolism is complete at doses up to 25-50 g or 40-75 ml; at higher dosages, a proportion may be excreted unchanged.
The information provided in Pharmacotherapeutic group of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Pharmacotherapeutic group in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
The information provided in Preclinical safety data of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Preclinical safety data in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
Preclinical data based on studies of single and repeated dose toxicity reveal no special hazards for humans. A long-term animal study does not give reference to tumorigenic potential. Lactulosum Polfarmex was not teratogenic in mice, rats and rabbits. After oral administration systemic toxicity is not to be expected due to the pharmacological and pharmacokinetic properties of Lactulosum Polfarmex.
The information provided in Incompatibilities of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Incompatibilities in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
The information provided in Special precautions for disposal and other handling of Lactulosum Polfarmex is based on data of another medicine with exactly the same composition as the Lactulosum Polfarmex. . Be careful and be sure to specify the information on the section Special precautions for disposal and other handling in the instructions to the drug Lactulosum Polfarmex directly from the package or from the pharmacist at the pharmacy.
Lactulosum Polfarmex price
https://www.drugs.com/search.php?searchterm=lactulosum-polfarmex
https://pubmed.ncbi.nlm.nih.gov/?term=lactulosum-polfarmex